Morphine Withdrawn Phase 2 Trials for Pain, Chronic Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03275012Efficacy and Safety Study of Gabapentin as add-on to Morphine in Paediatric Patients Affected by Chronic Pain
NCT00943566A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer